Back
Neurogene, Inc. 10K Form
Sell
36
NGNE
Neurogene, Inc.
Last Price:
$20.30
Seasonality Move:
21.08%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive NGNE News And Ratings
See the #1 stock for the next 7 days that we like better than NGNE
NGNE Financial Statistics
Sales & Book Value
| Annual Sales: | $925K |
|---|---|
| Cash Flow: | $-19.8M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $17.97 |
| Price / Book: | 1.18 |
Profitability
| EPS (TTM): | -4.42770 |
|---|---|
| Net Income (TTM): | $-85.1M |
| Gross Margin: | $-2.3M |
| Return on Equity: | -33.3% |
| Return on Assets: | -30.38% |
Neurogene, Inc. Earnings Forecast
Key Neurogene, Inc. Financial Ratios
-
The Gross Profit Margin over the past 14 years for NGNE is -251.03%.
-
The Selling, General & Administrative Expenses for NGNE have been equal to 2,444.65% of Gross Profit Margin.
-
The Research & Development expenses have been 6,585.62% of Revenue.
-
The Net Earning history of NGNE is -8,123.68% of Total Revenues.
-
Per Share Earnings over the last 14 years have been positive in 5 years.
Neurogene, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | NGNE |
| Website: | neurogene.com |
Debt
| Debt-to-Equity Ratio: | 0.04 |
|---|---|
| Current Ratio: | 18.37 |
| Quick Ratio: | 18.04 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
NGNE Technical Analysis vs Fundamental Analysis
Sell
36
Neurogene, Inc. (NGNE)
is a Sell
Is Neurogene, Inc. a Buy or a Sell?
-
Neurogene, Inc. stock is rated a SellThe current Neurogene, Inc. [NGNE] share price is $20.28. The Score for NGNE is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.